InsiderTrades

Form 4 for NGVT Ingevity Corp

Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001653477-25-000038 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-03-04 2025-02-28 NGVT Fisher Ryan C. SVP, Gen. Counsel, Sec F - Tax $47.66 -753 11.0K -6% -$35.9K
2025-03-04 2025-02-28 NGVT Fisher Ryan C. SVP, Gen. Counsel, Sec A - Grant $0.00 +4,715 15.2K +45% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-28 F D 94 $47.66 11,181 D — — (F1) Shares withheld by the Company to satisfy tax withholding obligations related to the 2022 restricted stock units ("RSUs") that vested on February 28, 2025.
2 Common Common Stock 2025-02-28 A A 4,715 $0.00 15,237 D — — (F4) Grant of RSUs pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2026, 2027, and 2028.
3 Common Common Stock 2025-02-28 F D 107 $47.66 10,522 D — — (F3) Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested on February 28, 2025.
4 Common Common Stock 2025-02-28 F D 357 $47.66 10,629 D — — (F3) Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested on February 28, 2025.
5 Common Common Stock 2025-02-28 F D 195 $47.66 10,986 D — — (F2) Shares withheld by the Company to satisfy tax withholding obligations related to the 2023 RSUs that vested on February 28, 2025.